Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide products, Wegovy (obesity ... as seen in the chart below.

Malaysia is one of the most obese countries in Asia, with half of its adult population classified as overweight. The nation is facing a growing childhood obesity epidemic, which has yet to be ...

One of the primary catalysts propelling the healthy snacks market forward is the alarming increase in global obesity rates. As individuals become more health-conscious and grapple with concerns about ...

Wegovy-maker Novo Nordisk said today its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

Wider card acceptance and contactless cards will help drive this growth. Malaysia’s payment card market— including ...

THURSDAY, Feb. 20, 2025 (HealthDay News) -- The number of U.S. adults with severe obesity increased from 2013 to 2023, according to a research letter published online Feb. 13 in the Journal of the ...

Excess fat mass estimated by waist-circumference-to-height ratio predicts the risk of liver damage better than body mass ...

A total of 29 abstracts will be presented, including trials investigating the efficacy and safety of CagriSema in people with overweight/obesity (REDEFINE 1) and those with overweight/obesity and ...

As in other areas of the country’s energy sector, the state is playing a leading role in developing renewable energy projects ...

"The report shines a necessary spotlight on a crisis that has long been ignored: skyrocketing rates of obesity, diabetes, autoimmune disease, developmental issues and mental health challenges ...

his ministry is also employing a comprehensive approach through the establishment of the Taskforce Committee to Tackle Obesity in Malaysia, comprising various ministries, departments and agencies.